This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Metabolix CEO To Speak At 4th Annual Next Generation Bio-Based Chemicals Summit

Metabolix, Inc. (NASDAQ: MBLX), a leading industrial biotechnology company focused on developing clean, sustainable solutions for plastics, chemicals and energy, today announced that President and CEO, Richard P. Eno, will present at the 4th Annual Next Generation Bio-Based Chemicals Summit’s “Molecules to Market” symposium. Mr. Eno’s presentation, “Suppliers’ Perspectives on Bringing a Novel BioPlastic Resin to Market,” will discuss the importance of foundational technology in accessing different biobased markets, and how to build a successful commercial model – drawing on Metabolix's own experience in biotechnology scale‐up.

What:

  “Suppliers’ Perspectives on Bringing a Novel BioPlastic Resin to Market”
 

Who:

Richard Eno, president and CEO, Metabolix, Inc.
 

When:

Monday, January 28, 2013 from 2:45-3:15 p.m. PT

 

Where:

4 th Annual Next Generation Bio-Based Chemicals Summit

Hilton Del Mar
3939 Ocean Bluff Avenue, San Diego, CA 92130

About the Speaker

Richard P. Eno has served as president, CEO and director since March 2008. Mr. Eno has more than 25 years of professional experience in the chemicals and energy business. Prior to joining Metabolix, Mr. Eno served as vice president, leader global oil & gas sector at CRA International, a leading provider of management consulting services and economic and financial expertise to global companies. Earlier in his career, he held various roles at Arthur D. Little and Chevron Corporation. Mr. Eno holds a bachelor of science degree in chemical engineering from Cornell University, a master of business administration degree from the University of Houston and is a chartered financial analyst.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs